Silvia Morbelli is a Full Professor and head of Nuclear Medicine at the University of Turin. She holds a PhD in Applied Neurosciences. Prof Morbelli has made contributions related to the use of neuroimaging tools as diagnostic and prognostic biomarkers in the earliest and preclinical stages of Neurodegenerative Dementia and Parkinsonian Syndromes. She is especially interested in the use of Molecular Imaging to disclose networks underlying different clinical phenotypes as well as brain reserve in Alzheimer’s and Lewy Body Diseases. She served as Chair of the Neuroimaging Committee of the European Association of Nuclear Medicine from 2020 to 2022.
Silvia Morbelli has received speaker honoraria from Eli-Lilly, Life Molecular Imaging, Novartis and GE Healthcare.
